Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa

No abstract is available for this paper.

• Publication year

  1996

• Venue

  European Journal of Cancer Prevention

• Publication date

  1996-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00008469-199606000-00005PMID 8818606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression pattern of breast‐cancer‐associated protein pS2/BCEI in colorectal tumors

  2007cited by this paper
• Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach

  2005cited by this paper
• Signet ring cell carcinoma in hyperplastic polyp.

  1995cited by this paper
• Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach

  1995cited by this paper
• New elements for an updated classification of the carcinomas of the stomach.

  1995cited by this paper
• Carcinoma arising in gastric hyperplastic polyps.

  1995cited by this paper
• Trefoil peptides: a new family of gastrointestinal molecules.

  1994cited by this paper
• Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: Delineation of epithelial phenotype

  1994cited by this paper
• T (Thomsen–Friedenreich) antigen and other simple mucin‐type carbohydrate antigens in precursor lesions of gastric carcinoma

  1994cited by this paper
• Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia

  1994cited by this paper
• Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage.

  1993cited by this paper
• Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach.

  1993cited by this paper
• Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion.

  1993cited by this paper
• hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.

  1993cited by this paper
• Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease.

  1993cited by this paper
• The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in ‘gastric metaplasia’ of the proximal duodenum: Implications for the nature of ‘gastric metaplasia’

  1993cited by this paper
• pS2 protein in gastric carcinoma and normal gastric mucosa: Association with clinicopathological parameters and patient survival

  1993cited by this paper
• Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family

  1993cited by this paper
• P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism.

  1992cited by this paper
• Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

  1992cited by this paper
• Signet ring cell carcinoma of the stomach: a morphometric, ultrastructural, and DNA cytometric study.

  1992cited by this paper
• Breast cancer-associated protein pS2 expression in tumors of the biliary tract.

  1991cited by this paper
• Antipeptide antibodies against the pNR‐2 oestrogen‐regulated protein of human breast cancer cells and detection of pNR‐2 expression in normal tissues by immunohistochemistry

  1991cited by this paper
• Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma.

  1991cited by this paper
• Expression of the pNR-2/pS2 protein in diverse human epithelial tumours.

  1991cited by this paper
• Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract.

  1991cited by this paper
• Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues

  1990cited by this paper
• Gastric precancerous process in a high risk population: cross-sectional studies.

  1990cited by this paper
• Gastric precancerous process in a high risk population: cohort follow-up.

  1990cited by this paper
• Expression of the pS2 gene in normal, benign and neoplastic human stomach

  1989cited by this paper
• Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa.

  1988cited by this paper
• Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases

  1988cited by this paper
• Chronic gastritis: a clinico-pathological classification.

  1988cited by this paper
• Dysplasia of Nonmetaplastic Gastric Mucosa: A Proposal for its Classification and its Possible Relationship to Diffuse‐Type Gastric Carcinoma

  1988cited by this paper
• Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2.

  1987cited by this paper
• Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of "early" and "advanced" tumours.

  1987cited by this paper
• The amino acid sequence of pancreatic spasmolytic polypeptide.

  1985cited by this paper
• Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach.

  1985cited by this paper
• Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line.

  1982cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• INTESTINAL METAPLASIA WITH COLONIC‐TYPE SULPHOMUCINS IN THE GASTRIC MUCOSA; ITS ASSOCIATION WITH GASTRIC CARCINOMA

  1980cited by this paper
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

  1965cited by this paper

• Immunoexpression of Trefoil Factor 1 in Non-Neoplastic and Neoplastic Canine Gastric Tissues

  2021cites this paper
• A functional polymorphism in TFF1 promoter is associated with the risk and prognosis of gastric cancer

  2018cites this paper
• Tesi di Dottorato Role of TFF 1 in tumor progression

  2017cites this paper
• C/EBPβ regulates homeostatic and oncogenic gastric cell proliferation

  2016cites this paper
• Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness

  2015cites this paper
• Role of Gastrokine 1 in Gastric Cancer: A Potential Diagnostic Marker and Antitumor Drug

  2014cites this paper
• The incidence and pathogenesis of 'recurrent' Barrett's metaplasia following oesophagectomy (neo-Barrett's)

  2013cites this paper
• Role of trefoil factor 1 in gastric cancer and relationship between trefoil factor 1 and gastrokine 1.

  2012cites this paper
• Molecular Characterization of Trefoil factor 1 in Gastric Carcinoma

  2012cites this paper
• GATA Factors in Gastrointestinal Malignancy

  2011cites this paper
• Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.

  2011cites this paper
• Molecular Pathogenesis of Gastric Cancer

  2010cites this paper
• Molecular Targets in Gastric Cancer and Apoptosis

  2009cites this paper
• Cancer Genetics of Human Gastric Adenocarcinoma

  2009cites this paper
• Apoptosis in Carcinogenesis and Chemotherapy

  2009cites this paper
• Review article: regulation of TFF1 (pS2) expression in gastric epithelial cells

  2006cites this paper
• Pathologic risk factors of adenocarcinoma of the gastric cardia and gastroesophageal junction.

  2006cites this paper
• Trefoil factors

  2005cites this paper
• Trefoil factors: from ulceration to neoplasia.

  2005cites this paper
• Molecular biology of gastric cancer.

  2002cites this paper
• Loss of Heterozygosity and Promoter Methylation, but not Mutation, May Underlie Loss of TFF1 in Gastric Carcinoma

  2002cites this paper
• Molecular and biologic basis of upper gastrointestinal malignancy. Gastric carcinoma.

  2002cites this paper
• Trefoil peptides in airway epithelium: an important addition to the plethora of peptides.

  2001cites this paper
• Current thoughts on the histopathogenesis of gastric cancer.

  2001cites this paper
• Prognostic Significance of Cytosolic pS2 Protein Content in Gastric Cancer

  2001cites this paper
• Mapping of a new target region of allelic loss at 21q22 in primary gastric cancers.

  2000cites this paper
• Tobacco smoking and vitamin C concentration in gastric juice in healthy subjects and patients with Helicobacter pylori infection

  2000cites this paper
• Trefoil factor family domain peptides in the human respiratory tract

  2000cites this paper
• Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6)

  2000cites this paper
• Somatic mutations of the trefoil factor family 1 gene in gastric cancer.

  2000cites this paper
• Hepatocyte Nuclear Factor 3 (Winged Helix Domain) Activates Trefoil Factor Gene TFF1 through a Binding Motif Adjacent to the TATAA Box

  1999cites this paper
• Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus

  1999cites this paper
• Trefoil peptides

  1999cites this paper
• Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.

  1999cites this paper
• Patterns of expression of trefoil peptides and mucins in gastric polyps with and without malignant transformation

  1999cites this paper
• causes tyrosine phosphorylation of

  1999cites this paper
• The trefoil peptide TFF1 inhibits the growth of the human gastric adenocarcinoma cell line AGS

  1999cites this paper
• Loss of pS2 Protein Expression Is an Early Event of Intestinal‐type Gastric Cancer

  1998cites this paper
• Trefoil peptides: from structure to function

  1997cites this paper
• Trefoil factor family domain peptides

  1997cites this paper